Capstone Asset Management’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-6,392
Closed -$643K 1682
2014
Q4
$643K Sell
6,392
-1,200
-16% -$93.3K 0.02% 882
2014
Q3
$504K Buy
7,592
+210
+3% +$13.8K 0.02% 1015
2014
Q2
$515K Sell
7,382
-100
-1% -$6.8K 0.02% 1049
2014
Q1
$547K Sell
7,482
-180
-2% -$13.4K 0.02% 996
2013
Q4
$528K Sell
7,662
-26,538
-78% -$1.72M 0.02% 1089
2013
Q3
$2.17M Buy
34,200
+1,820
+6% +$110K 0.05% 414
2013
Q2
$1.56M Buy
+32,380
New +$1.59M 0.04% 503

Capstone Asset Management's CBST Position: Q1 2015 in Review

Capstone Asset Management sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 6,392 shares — an estimated $643K sold.

Capstone Asset Management first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $2.17M in Q3 2013. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

  • Capstone Asset Management reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Capstone Asset Management sold 6,392 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $643K.
  • Capstone Asset Management first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • Capstone Asset Management's CUBIST PHARMACEUTICALS INC position peaked at $2.17M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on Capstone Asset Management's 13F filing for Q1 2015, filed 10 Apr 2015.